Employees Retirement System of Texas’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-56,540
Closed -$242K 889
2021
Q2
$242K Sell
56,540
-30,350
-35% -$130K ﹤0.01% 729
2021
Q1
$368K Hold
86,890
﹤0.01% 717
2020
Q4
$337K Hold
86,890
0.01% 628
2020
Q3
$350K Hold
86,890
0.01% 688
2020
Q2
$370K Hold
86,890
0.01% 706
2020
Q1
$365K Hold
86,890
0.01% 712
2019
Q4
$341K Hold
86,890
0.01% 765
2019
Q3
$765K Buy
86,890
+2,890
+3% +$27.3K 0.01% 767
2019
Q2
$777K Hold
84,000
0.01% 859
2019
Q1
$540K Buy
84,000
+43,000
+105% +$280K 0.01% 948
2018
Q4
$387K Hold
41,000
0.01% 991
2018
Q3
$825K Buy
41,000
+23,000
+128% +$601K 0.01% 896
2018
Q2
$525K Buy
+18,000
New +$556K 0.01% 1003

Other funds holding LJPC

Employees Retirement System of Texas's LJPC Position: Q3 2021 in Review

Employees Retirement System of Texas sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2021, closing a stake of 56,540 shares — an estimated $242K sold.

Employees Retirement System of Texas first reported a position in LJPC in Q2 2018 and held it in 13 quarters. The position peaked at $825K in Q3 2018. 54 funds tracked by Wall St. Rank hold LJPC as of Q3 2021.

  • Employees Retirement System of Texas reported no remaining La Jolla Pharmaceutical Company position as of Q3 2021 after selling out during the quarter.
  • Employees Retirement System of Texas sold 56,540 La Jolla Pharmaceutical Company shares in Q3 2021, an estimated $242K.
  • Employees Retirement System of Texas first reported a position in La Jolla Pharmaceutical Company in Q2 2018 and held it in 13 quarters.
  • Employees Retirement System of Texas's La Jolla Pharmaceutical Company position peaked at $825K in Q3 2018.
  • 54 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2021.

Based on Employees Retirement System of Texas's 13F filing for Q3 2021, filed 12 Nov 2021.